Blockage of urokinase receptor reduces in vitro the motility and the deformability of endothelial cells

[1]  P. Carmeliet,et al.  Gene Targeting and Gene Transfer Studies of the Biological Role of the Plasminogen/Plasmin System , 1995, Thrombosis and Haemostasis.

[2]  T. L. Moser,et al.  Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells. , 1995, The Biochemical journal.

[3]  S. Mandriota,et al.  Vascular Endothelial Growth Factor Increases Urokinase Receptor Expression in Vascular Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.

[4]  J J Fredberg,et al.  Urokinase receptor mediates mechanical force transfer across the cell surface. , 1995, The American journal of physiology.

[5]  O. Majdic,et al.  Urokinase plasminogen activator receptor, beta 2-integrins, and Src- kinases within a single receptor complex of human monocytes , 1995, The Journal of experimental medicine.

[6]  K. Kario,et al.  The Strong Positive Correlation between Factor VII Clotting Activity Using Bovine Thromboplastin and the Activated Factor VII Level , 1995, Thrombosis and Haemostasis.

[7]  S. Rosenberg,et al.  Identification of the urokinase receptor as an adhesion receptor for vitronectin. , 1994, The Journal of biological chemistry.

[8]  J. Soria,et al.  Blockage of the urokinase receptor on the cell surface: Construction and characterization of a hybrid protein consisting of the N‐terminal fragment of human urokinase and human albumin , 1994, FEBS letters.

[9]  S. Waxman,et al.  Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells , 1994, The Journal of cell biology.

[10]  L. Orci,et al.  Upregulation of urokinase receptor expression on migrating endothelial cells , 1993, The Journal of cell biology.

[11]  W. Birchmeier,et al.  Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. , 1992, The EMBO journal.

[12]  R. Hammer,et al.  LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation , 1992, Cell.

[13]  L. Orci,et al.  Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. , 1991, Biochemical and biophysical research communications.

[14]  Harold E. Dvorak,et al.  Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels , 1991, The Journal of experimental medicine.

[15]  D. Rifkin,et al.  Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor , 1991, The Journal of cell biology.

[16]  A. Mazar,et al.  An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells. , 1990, Biochemical and biophysical research communications.

[17]  E. Appella,et al.  The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. , 1987, The Journal of biological chemistry.

[18]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[19]  P. Mignatti.  The fibrinolytic system and angiogenesis , 1993 .

[20]  D. Rifkin,et al.  Biology and biochemistry of proteinases in tumor invasion. , 1993, Physiological reviews.